Functional Cytotoxicity Assays for T, B, and NK Cell Therapeutics
Cytolytic activity is a key measure of immunotherapy potency. Accelevir offers T cell killing assays, B cell cytotoxicity tests, and NK cell cytotoxicity assays to evaluate mechanism of action (MoA), potency, and functional persistence in preclinical and clinical programs.
Technical Capabilities:
- Flow cytometry-based killing assays.
- Real-time cytotoxicity using impedance-based platforms.
- Multi-species validation for GLP CAR-T potency testing.
Why Partner with Accelevir:
- Correlation with cytokine release profiles for safety assessment.
- Expertise in cytolytic assays for bispecific antibodies, CAR-T, and oncolytic viruses.